ATS vs. MLEC
ATS (ATS Corporation) and MLEC (Moolec Science SA Ordinary Shares) are both stocks. ATS operates in Specialty Industrial Machinery (Industrials), while MLEC operates in Biotechnology (Healthcare). Over the past 3 years, ATS returned -13.66%/yr vs -73.85%/yr for MLEC. At a correlation of -0.00, they often move in opposite directions.
Performance
ATS vs. MLEC - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ATS achieves a 4.76% return, which is significantly lower than MLEC's 112.10% return.
ATS
- 1D
- -3.38%
- 1M
- -10.15%
- YTD
- 4.76%
- 6M
- 12.48%
- 1Y
- -2.99%
- 3Y*
- -13.66%
- 5Y*
- 2.54%
- 10Y*
- 13.52%
MLEC
- 1D
- 18.59%
- 1M
- -22.49%
- YTD
- 112.10%
- 6M
- 20.00%
- 1Y
- -93.60%
- 3Y*
- -73.85%
- 5Y*
- —
- 10Y*
- —
ATS vs. MLEC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
ATS ATS Corporation | 4.76% | -9.65% | -29.23% | 39.27% |
MLEC Moolec Science SA Ordinary Shares | 112.10% | -96.82% | -67.48% | -72.97% |
Correlation
The correlation between ATS and MLEC is 0.02, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.02 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.01 |
Correlation (All Time) Calculated using the full available price history since Jan 4, 2023 | -0.00 |
Fundamentals
ATS:
$2.97B
MLEC:
$7.83M
ATS:
$850.80M
MLEC:
-$639.50K
ATS:
$357.63M
MLEC:
-$5.21M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ATS vs. MLEC — Risk / Return Rank
ATS
MLEC
ATS vs. MLEC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ATS Corporation (ATS) and Moolec Science SA Ordinary Shares (MLEC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ATS | MLEC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.38 | ||
| Sortino ratioReturn per unit of downside risk | +1.20 | ||
| Omega ratioGain probability vs. loss probability | 1.02 | 0.89 | +0.14 |
| Calmar ratioReturn relative to maximum drawdown | -0.12 | -0.96 | +0.85 |
| Martin ratioReturn relative to average drawdown | -0.23 | -1.12 | +0.88 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ATS | MLEC | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.07 | -0.45 | +0.38 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.06 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.37 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.35 | -0.39 | +0.75 |
Drawdowns
ATS vs. MLEC - Drawdown Comparison
The maximum ATS drawdown since its inception was -56.76%, smaller than the maximum MLEC drawdown of -99.88%. Use the drawdown chart below to compare losses from any high point for ATS and MLEC.
Loading charts...
Drawdown Indicators
| ATS | MLEC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -56.76% | -99.88% | +43.12% |
Max Drawdown (1Y)Largest decline over 1 year | -25.80% | -97.14% | +71.34% |
Max Drawdown (3Y)Largest decline over 3 years | -56.76% | -99.41% | +42.65% |
Max Drawdown (5Y)Largest decline over 5 years | -56.76% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -56.76% | — | — |
Current DrawdownCurrent decline from peak | -40.80% | -99.72% | +58.92% |
Average DrawdownAverage peak-to-trough decline | -19.90% | -91.72% | +71.82% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.78% | 84.59% | -71.81% |
Volatility
ATS vs. MLEC - Volatility Comparison
The current volatility for ATS Corporation (ATS) is 19.42%, while Moolec Science SA Ordinary Shares (MLEC) has a volatility of 32.40%. This indicates that ATS experiences smaller price fluctuations and is considered to be less risky than MLEC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ATS | MLEC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 19.42% | 32.40% | -12.98% |
Volatility (6M)Calculated over the trailing 6-month period | 32.82% | 164.00% | -131.18% |
Volatility (1Y)Calculated over the trailing 1-year period | 40.56% | 207.49% | -166.93% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 40.36% | 198.25% | -157.89% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 38.64% | 198.25% | -159.61% |
Dividends
ATS vs. MLEC - Dividend Comparison
Neither ATS nor MLEC has paid dividends to shareholders.
Financials
ATS vs. MLEC - Financials Comparison
This section allows you to compare key financial metrics between ATS Corporation and Moolec Science SA Ordinary Shares. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ATS and MLEC have a correlation of 0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
MLEC has higher volatility (32.40%) compared to ATS (19.42%). In terms of maximum drawdown, ATS dropped -56.76% vs MLEC's -99.88%.
ATS currently has the higher Sharpe Ratio (-0.07 vs -0.45), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ATS and MLEC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer